Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Bucerius, J; Ahmadzadehfar, H; Hortling, N; Joe, AY; Palmedo, H; Biersack, HJ.
Incidental diagnosis of a PSA-negative prostate cancer by 18FDG PET/CT in a patient with hypopharyngeal cancer
PROSTATE CANCER P D. 2007; 10(3): 307-310.
Doi: 10.1038/sj.pcan.4500959
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Bucerius Jan Alexander
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Diagnosis of prostate cancer ( PC) still remains critical as non-invasive screening with prostate specific-antigen (PSA) lacks to indicate malignancy of the prostate in some cases. Recent research has shown that clinically meaningful PC can develop in patients with a PSA value < 4 ng/ml, frequently defined as upper limit of normal serum PSA levels. Furthermore, both morphological ( computed tomography (CT), magnetic resonance imaging, transrectal ultrasound) and functional imaging with 18 fluorodeoxyglucose positron emission tomography (FDG-PET) are associated with several limitations for primary diagnosis of PC. We report a case of an incidentally diagnosed PSA-negative PC by (18)FDG PET/CT in a patient with a previous diagnosis of a hypopharyngeal cancer.
- Find related publications in this database (Keywords)
-
PSA
-
(18)FDG-PET/CT
-
prostate cancer